Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Open Access
- 7 May 2021
- journal article
- review article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 19 (1) , 1-13
Abstract
Neurodegenerative diseases like Alzheimer’s, Parkinson’s and Huntington’s disease involves abnormal aggregation and accumulation of toxic proteins aggregates. Post-translational modifications (PTMs) of the causative proteins play an important role in the etiology of disease as they could either slow down or accelerate the disease progression. Alzheimer disease is associated with the aggregation and accumulation of two major protein aggregates—intracellular neurofibrillary tangles made up of microtubule-associated protein Tau and extracellular Amyloid-β plaques. Post-translational modifications are important for the regulation of Tau`s function but an imbalance in PTMs may lead to abnormal Tau function and aggregation. Tau methylation is one of the important PTM of Tau in its physiological state. However, the methylation signature on Tau lysine changes once it acquires pathological aggregated form. Tau methylation can compete with other PTMs such as acetylation and ubiquitination. The state of PTM at these sites determines the fate of Tau protein in terms of its function and stability. The global methylation in neurons, microglia and astrocytes are involved in multiple cellular functions involving their role in epigenetic regulation of gene expression via DNA methylation. Here, we have discussed the effect of methylation on Tau function in a site-specific manner and their cross-talk with other lysine modifications. We have also elaborated the role of methylation in epigenetic aspects and neurodegenerative conditions associated with the imbalance in methylation metabolism affecting global methylation state of cells.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (CSIR NCL MLP029526)
This publication has 147 references indexed in Scilit:
- The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaquesActa Neuropathologica, 2013
- Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patientsTranslational Psychiatry, 2012
- Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approachActa Neuropathologica, 2011
- Nuclear Tau, a Key Player in Neuronal DNA ProtectionJournal of Biological Chemistry, 2011
- Epigenetic changes in Alzheimer's disease: Decrements in DNA methylationNeurobiology of Aging, 2010
- Acetylation of Tau Inhibits Its Degradation and Contributes to TauopathyNeuron, 2010
- Lysine Acetylation: Codified Crosstalk with Other Posttranslational ModificationsMolecular Cell, 2008
- Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cellsBritish Journal of Cancer, 2008
- Protein lysine methyltransferase G9a acts on non-histone targetsNature Chemical Biology, 2008
- Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCGJournal of Cellular Biochemistry, 2007